analyst
ZB
NASDAQ · ZBIO
Zenas BioPharma, Inc.
Healthcare · Biotechnology
$31.62
Up+$0.67 (+2.12%)
Updated Aug 22, 2026, 1:15 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.69B
- P/E ratio
- -9.52
- Dividend yield
- 0.00%
- 52-week range
- $16.41 – $34.05
- Volume
- 1.17M
- Avg. volume
- 419.1K
Price performance
ZBIO price history
1M range · 20 trading sessions · Daily adjusted prices
ZBIO closed at $31.62 after 20 trading sessions, up 4.05% for the selected period.
- Last close
- $31.62
- Period change
- +4.05%
- Period low
- $29.20
- Period high
- $32.82
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 20, 2026 | $30.72 | $32.20 | $29.50 | $31.62 | 1.17M |
| Aug 19, 2026 | $32.80 | $32.8899 | $30.92 | $31.25 | 2.7M |
| Aug 18, 2026 | $30.22 | $31.96 | $30.22 | $31.91 | 659.82K |
| Aug 17, 2026 | $29.95 | $30.81 | $28.72 | $30.50 | 490.11K |
| Aug 14, 2026 | $28.76 | $30.31 | $28.163 | $29.51 | 630.04K |
| Aug 13, 2026 | $30.39 | $31.00 | $27.81 | $29.20 | 881.51K |
| Aug 12, 2026 | $32.05 | $32.9734 | $31.12 | $31.29 | 461.6K |
| Aug 11, 2026 | $31.43 | $32.88 | $30.71 | $32.44 | 1.07M |
| Aug 10, 2026 | $32.24 | $32.695 | $31.605 | $31.99 | 409.92K |
| Aug 7, 2026 | $32.85 | $33.08 | $31.65 | $32.43 | 264.07K |
| Aug 6, 2026 | $31.51 | $33.00 | $31.32 | $32.17 | 676.93K |
| Aug 5, 2026 | $31.93 | $32.38 | $31.23 | $31.86 | 411.11K |
| Aug 4, 2026 | $31.09 | $31.73 | $30.4501 | $31.42 | 378.13K |
| Aug 3, 2026 | $32.075 | $32.18 | $30.33 | $31.13 | 429.28K |
| Jul 31, 2026 | $32.69 | $32.95 | $30.60 | $31.44 | 452.23K |
| Jul 30, 2026 | $31.37 | $32.96 | $30.75 | $32.27 | 738.02K |
| Jul 29, 2026 | $32.43 | $32.43 | $30.25 | $31.09 | 625.61K |
| Jul 28, 2026 | $32.64 | $33.30 | $31.81 | $32.29 | 773.85K |
| Jul 27, 2026 | $30.91 | $33.42 | $30.85 | $32.82 | 1.15M |
| Jul 24, 2026 | $31.30 | $31.30 | $30.09 | $30.39 | 558.98K |
Latest ZBIO news
The latest Smart Investors Daily articles mentioning ZBIO.
Stock researchResearch & News · SEC Filings
Loading stock research…